Abstract P3-04-01: Discovery of distinct sub-groups of ER positive breast cancers by DNA repair expression profiling: Implications for patient stratification and personalization of therapy
Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Ian O. Ellis(University of Nottingham), Emad A. Rakha(Nottingham University Hospitals NHS Trust), Paul M. Moseley(Nottingham University Hospitals NHS Trust), Christina J. Perry(Florey Institute of Neuroscience and Mental Health), Rachel Abbotts(University of Nottingham), Abhik Mukherjee(University of Nottingham), Devika Agarwal(University of Oxford), Stephanie Chan(Nottingham University Hospitals NHS Trust), Carlos Caldas(University of Cambridge), Rosalind L. Russell(Nottingham University Hospitals NHS Trust), TMA Abdel-Fatah(Nottingham University Hospitals NHS Trust), Graham Ball(Computer Algorithms for Medicine)
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
|New England Journal of Medicine|2020|1.8k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k